Package 43598-686-60

{"route": ["ORAL"], "spl_id": "75484338-6d78-877c-086f-61467c8dd5e4", "openfda": {"unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482515", "1482521", "1482525"], "spl_set_id": ["190fccbc-da3f-b175-ac02-f2c4307a15c3"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (43598-686-60)", "package_ndc": "43598-686-60", "marketing_start_date": "20250506"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (43598-686-90)", "package_ndc": "43598-686-90", "marketing_start_date": "20250506"}], "brand_name": "Eslicarbazepine Acetate", "product_id": "43598-686_75484338-6d78-877c-086f-61467c8dd5e4", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "43598-686", "generic_name": "Eslicarbazepine Acetate", "labeler_name": "Dr.Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eslicarbazepine Acetate", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "600 mg/1"}], "application_number": "ANDA211238", "marketing_category": "ANDA", "marketing_start_date": "20250506", "listing_expiration_date": "20261231"}